Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Breast Cancer
Related studies linked through entity extraction aliases.
Breath Test to Predict Breast Cancer and Outcome of Mammography
- Status
- UNKNOWN
- Phase
- N/A
Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias
- Status
- COMPLETED
- Phase
- PHASE2
ESPB and RIB for Pain Management Following Mastectomy Surgery
- Status
- COMPLETED
- Phase
- NA
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
- Status
- RECRUITING
- Phase
- NA
Meditation and Cancer, Pilot Feasibility Study (MAEva Pilot Study)
- Status
- COMPLETED
- Phase
- NA
Influence of Co-Vid 19 Pandemic on Screening Mammography Single Institution
- Status
- UNKNOWN
- Phase
- N/A
Cancer Surveillance and Support
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
The Engaging Primary Care in Cancer Survivorship (EPICS) Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Health Technologies Readiness in Breast Cancer Patients
- Status
- COMPLETED
- Phase
- N/A
Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant Chemotherapy
- Status
- RECRUITING
- Phase
- NA
TOPS for African American Breast Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer
- Status
- RECRUITING
- Phase
- NA
A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Developing a Virtual Stress Management Intervention for Spousal/Partnered Caregivers of Solid Tumor Cancer Patients.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Pilot Study of an NTproBNP Guided Strategy of Cardioprotection
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Inetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM Pathway
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Study to Evaluate Patient Reported Outcome (PRO) and Physical Activity in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Endocrine Therapy or Endocrine Monotherapy
- Status
- COMPLETED
- Phase
- NA
Prevention and Treatment of Pyrrolitinib-associated Diarrhea
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Letrozole
- Status
- COMPLETED
- Phase
- N/A